Iterum Therapeutics PLC
NASDAQ:ITRM

Watchlist Manager
Iterum Therapeutics PLC Logo
Iterum Therapeutics PLC
NASDAQ:ITRM
Watchlist
Price: 1.81 USD 2.26% Market Closed
Market Cap: 41.1m USD
Have any thoughts about
Iterum Therapeutics PLC?
Write Note

Wall Street
Price Targets

ITRM Price Targets Summary
Iterum Therapeutics PLC

Wall Street analysts forecast ITRM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ITRM is 7.65 USD with a low forecast of 5.05 USD and a high forecast of 10.5 USD.

Lowest
Price Target
5.05 USD
179% Upside
Average
Price Target
7.65 USD
323% Upside
Highest
Price Target
10.5 USD
480% Upside
Iterum Therapeutics PLC Competitors:
Price Targets
APLLTD
Alembic Pharmaceuticals Ltd
15% Upside
NWRN
Newron Pharmaceuticals SpA
96% Upside
2005
SSY Group Ltd
68% Upside
GLAND
Gland Pharma Ltd
0% Upside
600535
Tasly Pharmaceutical Group Co Ltd
21% Upside
688513
Chengdu Easton Biopharmaceuticals Co Ltd
32% Upside
000999
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
24% Upside

Revenue
Forecast

Revenue Estimate
Iterum Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Iterum Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Iterum Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-74%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ITRM's stock price target?
Price Target
7.65 USD

According to Wall Street analysts, the average 1-year price target for ITRM is 7.65 USD with a low forecast of 5.05 USD and a high forecast of 10.5 USD.

Back to Top